Geron Corporation (GERN)
NASDAQ: GERN · IEX Real-Time Price · USD
4.600
-0.070 (-1.50%)
Jul 19, 2024, 4:00 PM EDT - Market closed

Geron Revenue

Geron had revenue of $520.00K in the twelve months ending March 31, 2024, with 5.26% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $304.00K with 1,347.62% year-over-year growth. In the year 2023, Geron had annual revenue of $237.00K.

Revenue (ttm)
$520.00K
Revenue Growth
+5.26%
P/S Ratio
5,246.95
Revenue / Employee
$3,688
Employees
141
Market Cap
2.73B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023237.00K-359.00K-60.23%
Dec 31, 2022596.00K-797.00K-57.21%
Dec 31, 20211.39M1.14M450.59%
Dec 31, 2020253.00K-207.00K-45.00%
Dec 31, 2019460.00K-606.00K-56.85%
Dec 31, 20181.07M1,000.000.09%
Dec 31, 20171.07M-5.10M-82.72%
Dec 31, 20166.16M-30.21M-83.06%
Dec 31, 201536.37M35.22M3,054.47%
Dec 31, 20141.15M-130.00K-10.13%
Dec 31, 20131.28M-1.43M-52.64%
Dec 31, 20122.71M271.00K11.12%
Dec 31, 20112.44M-1.13M-31.57%
Dec 31, 20103.56M1.84M106.43%
Dec 31, 20091.73M-1.08M-38.42%
Dec 31, 20082.80M-4.82M-63.22%
Dec 31, 20077.62M4.35M132.59%
Dec 31, 20063.28M-2.88M-46.78%
Dec 31, 20056.16M5.11M484.81%
Dec 31, 20041.05M-121.00K-10.31%
Dec 31, 20031.17M-756.00K-39.17%
Dec 31, 20021.93M-2.03M-51.26%
Dec 31, 20013.96M-2.65M-40.08%
Dec 31, 20006.61M1.20M22.12%
Dec 31, 19995.41M-1.39M-20.38%
Dec 31, 19986.80M-456.00K-6.29%
Dec 31, 19977.25M1.96M37.03%
Dec 31, 19965.29M-197.00K-3.59%
Dec 31, 19955.49M--
Dec 31, 19940--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 8.97B
Astrana Health 1.45B
Progyny 1.11B
Certara 360.69M
MorphoSys AG 264.75M
Kymera Therapeutics 79.41M
Agios Pharmaceuticals 29.40M
SpringWorks Therapeutics 26.45M
Revenue Rankings